首页 | 本学科首页   官方微博 | 高级检索  
检索        

顺铂联合补中益气汤对A549/DDP荷瘤裸鼠移植瘤survivin蛋白表达的影响
引用本文:高原,刘赞,陈奇,王莹,王哲,井欢,刘春英.顺铂联合补中益气汤对A549/DDP荷瘤裸鼠移植瘤survivin蛋白表达的影响[J].肿瘤防治研究,2016,43(11):937-941.
作者姓名:高原  刘赞  陈奇  王莹  王哲  井欢  刘春英
作者单位:1. 110847 沈阳,辽宁中医药大学基础医学院病理教研室;2. 110179 沈阳,辽宁省医疗器械检验检测院;3. 110179 沈阳,辽宁省体育科学研究所生理研究室
基金项目:国家自然科学基金(81403303);中国博士后科学基金面上项目(2014M551122);中国博士后科学基金特别资助(2015T80266);辽宁省自然科学基金(2013020178)
摘    要:目的 探讨顺铂联合补中益气汤对A549/DDP荷瘤裸鼠移植瘤survivin蛋白表达的影响。方法 30只BALB/c-nu裸小鼠随机分为5组,A:荷瘤对照组、B:顺铂组、C:顺铂联合低剂量补中益气汤组、D:顺铂联合中剂量补中益气汤组、E:顺铂联合高剂量补中益气汤组。25 d后处死全部裸小鼠。测量移植瘤体积、重量并计算药物抑瘤率;Real-time PCR法检测移植瘤组织survivin mRNA的表达;Western blot法检测移植瘤组织survivin蛋白的表达。结果 顺铂联合低、中、高剂量组均较荷瘤对照组、顺铂组移植瘤体积显著缩小,重量显著减轻,差异有统计学意义;顺铂抑瘤率随着补中益气汤的剂量增加而增大;顺铂组、顺铂联合低剂量组较荷瘤对照组移植瘤组织中survivin的基因和蛋白表达上调,而顺铂联合中、高剂量组较荷瘤对照组survivin的基因和蛋白表达下调,差异均有统计学意义;顺铂联合低、中、高剂量补中益气汤组较顺铂组移植瘤组织中survivin的基因和蛋白表达均下调,差异均有统计学意义。结论 顺铂联合补中益气汤可通过下调survivin的表达改善A549/DDP荷瘤裸鼠移植瘤对顺铂的耐药性。

关 键 词:补中益气汤  肺腺癌  移植瘤  化疗耐药  survivin  
收稿时间:2016-01-18

Effect of Cisplatin Combined with Buzhong Yiqi Decoction on survivin Expression in Transplantation Tumor of Nude Mice with A549/DDP Cells
GAO Yuan,LIU Zan,CHEN Qi,WANG Ying,WANG Zhe,JING Huan,LIU Chunying.Effect of Cisplatin Combined with Buzhong Yiqi Decoction on survivin Expression in Transplantation Tumor of Nude Mice with A549/DDP Cells[J].Cancer Research on Prevention and Treatment,2016,43(11):937-941.
Authors:GAO Yuan  LIU Zan  CHEN Qi  WANG Ying  WANG Zhe  JING Huan  LIU Chunying
Institution:1. Department of Pathology, College of Basic Medical Science, Liaoning University of Chinese Traditional Medicine, Shenyang 110847, China; 2. Liaoning Medical Device Test Institute, Shenyang 110179, China; 3. Department of Sports Physiology, Liaoning Sports Science Research Institute, Shenyang 110179, China
Abstract:Objective To explore effect of cisplatin combined with Buzhong Yiqi decoction on survivin expression in transplantation tumor of nude mice with A549/DDP cells. Methods Thirty BALB/c-nu mice were randomly divided into five groups: A group (tumor control group), B group (cisplatin group), C group (cisplatin with low dose of Buzhong Yiqi decoction), D group (cisplatin with medium dose of Buzhong Yiqi decoction), E group (cisplatin with high dose of Buzhong Yiqi decoction). DDP or DDP and Buzhong Yiqi decoction were treated from 9 to 33 day, lastly the mice were executed. The volume and weight of transplantation tumors were measured; tumor inhibitory rate was calculated. Real-time PCR was used to determine the expression of survivin mRNA; Western blot was adopted to detect the expression of survivin protein. Results The volume and weight of transplantation tumors in C, D and E groups were significantly smaller than those in A and B groups. Tumor inhibitory rates were increased with the increasing dose of Buzhong Yiqi decoction. Compared with A group, the survivin gene and protein levels of transplantation tumors in B and C groups were higher, however, the results were lower in D and E groups. The survivin gene and protein expressions of transplantation tumors in C, D and E groups were significantly down-regulated, compared with B group. Conclusion Cisplatin combined with Buzhong Yiqi decoction could improve cisplatin resistance of transplantation tumor of nude mice with A549/DDP cells through down-regulating the gene and protein expression of survivin.
Keywords:Buzhong Yiqi decoction  Lung adenocarcinoma  Transplantation tumor  Chemotheraphy resistance  survivin  R734  2
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号